Verinata Health, is now part of Illumina, Inc., is driven by a sole, extraordinary purpose — maternal and fetal health. Our initial focus is to develop and offer non-invasive tests for early identification of fetal chromosomal abnormalities using our proprietary technologies. We aim to reduce the anxiety associated with today’s multi-step process, the unacceptable false-positive rates, the non-specific and sometimes confusing results of current prenatal screening methods, as well as the risk of current invasive procedures. In support of national guidelines recommending first trimester aneuploidy risk assessment, we believe women who desire such an assessment should be offered a single blood draw test with a definitive result. Verinata has completed its blinded pivotal study to clinically validate the sensitivity and specificity of its first prenatal test. The verifi™ prenatal test is a non-invasive assay for the determination of the three primary chromosomal aneuploidies for trisomies 21, 18 and 13.
Our company is located in Redwood City, CA. We are looking for enthusiastic and self-motivated talent with demonstrated experience in working in a collaborative environment to further advance maternal and fetal health care. This opportunity to work within a small entrepreneurial team offers tremendous growth opportunities, with competitive benefits and compensation.
We are seeking a QA Specialist II OR III who is highly motivated to join our efforts to offer non-invasive prenatal testing.